FI130199B - Förfarande för att bestämma om ett subjekt löper risk att utveckla en njursjukdom - Google Patents

Förfarande för att bestämma om ett subjekt löper risk att utveckla en njursjukdom Download PDF

Info

Publication number
FI130199B
FI130199B FI20215180A FI20215180A FI130199B FI 130199 B FI130199 B FI 130199B FI 20215180 A FI20215180 A FI 20215180A FI 20215180 A FI20215180 A FI 20215180A FI 130199 B FI130199 B FI 130199B
Authority
FI
Finland
Prior art keywords
fatty acids
disease
renal
icd
risk
Prior art date
Application number
FI20215180A
Other languages
English (en)
Finnish (fi)
Other versions
FI20215180A1 (sv
Inventor
Peter Würtz
Heli Julkunen
Original Assignee
Nightingale Health Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nightingale Health Oy filed Critical Nightingale Health Oy
Priority to FI20215180A priority Critical patent/FI130199B/sv
Priority to PCT/FI2022/050106 priority patent/WO2022175599A1/en
Publication of FI20215180A1 publication Critical patent/FI20215180A1/sv
Application granted granted Critical
Publication of FI130199B publication Critical patent/FI130199B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
    • G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4728—Details alpha-Glycoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI20215180A 2021-02-19 2021-02-19 Förfarande för att bestämma om ett subjekt löper risk att utveckla en njursjukdom FI130199B (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20215180A FI130199B (sv) 2021-02-19 2021-02-19 Förfarande för att bestämma om ett subjekt löper risk att utveckla en njursjukdom
PCT/FI2022/050106 WO2022175599A1 (en) 2021-02-19 2022-02-18 Method for determining whether a subject is at risk of developing a renal disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20215180A FI130199B (sv) 2021-02-19 2021-02-19 Förfarande för att bestämma om ett subjekt löper risk att utveckla en njursjukdom

Publications (2)

Publication Number Publication Date
FI20215180A1 FI20215180A1 (sv) 2022-08-20
FI130199B true FI130199B (sv) 2023-04-17

Family

ID=80595316

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20215180A FI130199B (sv) 2021-02-19 2021-02-19 Förfarande för att bestämma om ett subjekt löper risk att utveckla en njursjukdom

Country Status (2)

Country Link
FI (1) FI130199B (sv)
WO (1) WO2022175599A1 (sv)

Also Published As

Publication number Publication date
FI20215180A1 (sv) 2022-08-20
WO2022175599A1 (en) 2022-08-25

Similar Documents

Publication Publication Date Title
FI130199B (sv) Förfarande för att bestämma om ett subjekt löper risk att utveckla en njursjukdom
FI130449B (sv) Förfarande för att bestämma om ett subjekt löper risk att utveckla rörelseorganens sjukdom och/eller bindvävssjukdom
FI130695B1 (sv) Förfarande för att bestämma om en person har risk att utveckla ett metaboliskt tillstånd som anknyter till vätskebalansen i blodet
US20240310385A1 (en) Use of glycoprotein acetyls for determining the risk of developing atrial fibrillation and/or flutter
US20230393158A1 (en) Method for determining whether a subject is at risk of developing a mental and/or a behavioural disorder
WO2022101554A1 (en) Method for determining whether a subject is at risk of developing a chronic respiratory disease
US20240302388A1 (en) Method for determining whether a subject is at risk of dying from breast cancer or prostate cancer
CA3208919A1 (en) Use of glycoprotein acetyls for determining the risk of developing a gallbladder disorder
US20230243851A1 (en) Method for determining whether a subject has a disease or condition or is at risk of developing a disease or condition

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NIGHTINGALE HEALTH OYJ